ANTEX BIOLOGICS INC
10QSB, EX-27, 2000-08-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ANTEX BIOLOGICS INC, 10QSB, 2000-08-10
Next: HARRIS & HARRIS GROUP INC /NY/, 10-Q, 2000-08-10



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      14,020,569
<SECURITIES>                                         0
<RECEIVABLES>                                   56,804
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            14,196,678
<PP&E>                                       1,383,620
<DEPRECIATION>                               (534,811)
<TOTAL-ASSETS>                              15,219,378
<CURRENT-LIABILITIES>                        1,029,267
<BONDS>                                              0
                                0
                                    857,945
<COMMON>                                       104,139
<OTHER-SE>                                  13,118,821
<TOTAL-LIABILITY-AND-EQUITY>                15,219,378
<SALES>                                              0
<TOTAL-REVENUES>                               156,871
<CGS>                                                0
<TOTAL-COSTS>                                3,312,853
<OTHER-EXPENSES>                               348,005
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,807,977)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,807,977)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,807,977)
<EPS-BASIC>                                     (0.44)
<EPS-DILUTED>                                   (0.44)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission